CNN —
Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck.
A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will learn whether they’ll gain such coverage for the coming year during open enrollment, which launches this month at many companies.
GLP-1 drugs, which treat diabetes, obesity and certain other conditions, have become super popular since they came on the market a few years ago because they help patients shed pounds. While employers typically cover the medications for diabetes, fewer
→ Continue reading at CNN - Business News
